Sloan-Kettering - Melanoma: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for melanoma. To learn more about a study, choose from the list below.

Melanoma

top

A Multicenter Treatment Protocol for Compassionate Use of Ipilimumab Monotherapy in Patients with Unresectable Stage III or Stage IV Melanoma
Wolchok, Jedd, MD, PhD

[Protocol 07-156]
A Phase I Study of PLX4032 in Patients with Metastatic Melanoma
Chapman, Paul, MD

[Protocol 06-148]
A Phase I Study of Sorafenib plus Isolated Limb Infusion of Melphalan in Patients with Locally Advanced Malignant Melanoma
Brady, Mary, MD

[Protocol 08-052]
A Phase II Study of BMS-663513 as Second-Line Monotherapy in Patients with Previously Treated Unresectable Stage III or Stage IV Melanoma
Wolchok, Jedd, MD, PhD

[Protocol 08-027]
A Phase II Study of IMC-1121B with or without Dacarbazine in Patients with Metastatic Malignant Melanoma
Carvajal, Richard, MD

[Protocol 07-136]
A Phase II Study of Imatinib in Patients with Inoperable Stage III or IV Melanoma with Alterations in the C-KIT Protein
Carvajal, Richard, MD

[Protocol 07-014]
A Phase III Study of Ipilimumab versus Placebo after Complete Resection of High-Risk Stage III Melanoma
Wolchok, Jedd, MD, PhD

[Protocol 08-085]
A Phase Ia/Ib Study of a DNA Vaccine in Patients with Stage IIB-IV Malignant Melanoma
Wolchok, Jedd, MD, PhD

[Protocol 07-003]
Health Communication in Families
Hay, Jennifer, PhD

[Protocol 03-088]
Illness Related Distress in Women with Clinically Localized Cutaneous Melanoma
Brady, Mary, MD

[Protocol 08-096]
Injection of Melanoma Patients with Mouse TRYP2 DNA: A Phase I Trial to Assess Safety and Immune Response
Wolchok, Jedd, MD, PhD

[Protocol 06-052]
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
Oliveria, Susan, ScD, MPH

[Protocol 06-128]
Pilot Trial to Determine Toxicity and Antibody Responses with a Vaccine Containing GD2 Lactone and GD3 Lactone in Patients with Disease-Free Stage III or IV Melanoma
Chapman, Paul, MD

[Protocol 06-086]